These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25732939)

  • 1. Measles in Morocco: epidemiological profile and impact of vaccination strategy.
    Cheikh A; Ziani M; Cheikh Z; Barakat A; El Menzhi O; Braikat M; Benomar A; Cherrah Y; El Hassani A
    Adv Ther; 2015 Feb; 32(2):172-83. PubMed ID: 25732939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
    PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First 5 years of measles elimination in southern Africa: 1996-2000.
    Biellik R; Madema S; Taole A; Kutsulukuta A; Allies E; Eggers R; Ngcobo N; Nxumalo M; Shearley A; Mabuzane E; Kufa E; Okwo-Bele JM
    Lancet; 2002 May; 359(9317):1564-8. PubMed ID: 12047966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students.
    Abd Elaziz KM; Sabbour SM; Dewedar SA
    Vaccine; 2010 Nov; 28(47):7563-8. PubMed ID: 20797454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
    BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward measles elimination--Japan, 1999-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(38):1049-52. PubMed ID: 18818586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global measles control and regional elimination, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Dec; 48(49):1124-30. PubMed ID: 10634347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide measles vaccination campaign for children aged 6 months-12 years--Afghanistan, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Apr; 52(16):363-6. PubMed ID: 12749476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward interruption of endemic measles transmission in Tunisia.
    Garbouj M; Slim A; Ghorbal MB; Khamassi S; Gaafar T; Moshni E; Lievano F
    J Infect Dis; 2003 May; 187 Suppl 1():S172-6. PubMed ID: 12721910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is measles elimination possible in WHO European region up to 2015?
    Paslawska A; Mrozek-Budzyn D
    Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in global measles control, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(4):73-8. PubMed ID: 22298303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards measles elimination in Singapore.
    Ho HJ; Low C; Ang LW; Cutter JL; Tay J; Chan KP; Ooi PL; Thoon KC; Goh KT
    Vaccine; 2014 Dec; 32(51):6927-6933. PubMed ID: 25444818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.